TrialCancer chemotherapy and pharmacology2013

A phase I/II study of carfilzomib 2-10-min infusion in patients with advanced solid tumors.

Kyriakos P Papadopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.